144 related articles for article (PubMed ID: 33541123)
1. Genetic variants in
He Y; Wang G; Wang Q; Zhao Z; Gan L; Yang S; Wang Y; Guo S; An J; Zhang J; Zhang Z; Zhou F
Future Oncol; 2021 Mar; 17(7):795-805. PubMed ID: 33541123
[No Abstract] [Full Text] [Related]
2. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
[TBL] [Abstract][Full Text] [Related]
3. Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer.
Zhou F; He X; Liu H; Zhu Y; Jin T; Chen C; Qu F; Li Y; Bao G; Chen Z; Xing J
Cancer; 2012 Feb; 118(4):937-46. PubMed ID: 21773969
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid synthesis pathway genetic variants and clinical outcome of non-small cell lung cancer patients after surgery.
Jin X; Zhang KJ; Guo X; Myers R; Ye Z; Zhang ZP; Li XF; Yang HS; Xing JL
Asian Pac J Cancer Prev; 2014; 15(17):7097-103. PubMed ID: 25227797
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms at HORMAD2 and prognosis in advanced non-small-cell lung cancer patients.
Zhang K; Tang S; Cao S; Hu L; Pan Y; Ma H; Guo X; Wu S; Shen H; Hu Z
Cancer Epidemiol; 2014 Aug; 38(4):414-8. PubMed ID: 24797335
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery.
Liu B; Liu Q; Song Y; Li X; Wang Y; Wan S; Zhang Z; Su H
Med Oncol; 2014 Apr; 31(4):877. PubMed ID: 24567056
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of EpCAM gene and prognosis for non-small-cell lung cancer in Han Chinese.
Yang Y; Fei F; Song Y; Li X; Zhang Z; Fei Z; Su H; Wan S
Cancer Sci; 2014 Jan; 105(1):89-96. PubMed ID: 24304228
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
11. Genetic variations in monocarboxylate transporter genes as predictors of clinical outcomes in non-small cell lung cancer.
Guo X; Chen C; Liu B; Wu Y; Chen Y; Zhou X; Huang X; Li X; Yang H; Chen Z; Xing J
Tumour Biol; 2015 May; 36(5):3931-9. PubMed ID: 25578492
[TBL] [Abstract][Full Text] [Related]
12. Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients.
Dong H; Bao D; Guo X; Hu J; Li X; Wan S; Xing J
Tumour Biol; 2015 Sep; 36(9):7151-7. PubMed ID: 25877757
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
[TBL] [Abstract][Full Text] [Related]
14. Genetic variants of CHRNA5-A3 and CHRNB3-A6 predict survival of patients with advanced non-small cell lung cancer.
Wang Y; Peng X; Zhu L; Hu L; Song Y
Oncotarget; 2016 May; 7(18):26436-43. PubMed ID: 27050379
[TBL] [Abstract][Full Text] [Related]
15. Genetic variations in SLC3A2/CD98 gene as prognosis predictors in non-small cell lung cancer.
Guo X; Li H; Fei F; Liu B; Li X; Yang H; Chen Z; Xing J
Mol Carcinog; 2015 Jun; 54 Suppl 1():E52-60. PubMed ID: 24782339
[TBL] [Abstract][Full Text] [Related]
16. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract][Full Text] [Related]
17. The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer.
Yi C; Mu L; de la Longrais IA; Sochirca O; Arisio R; Yu H; Hoffman AE; Zhu Y; Katsaro D
Breast Cancer Res Treat; 2010 Apr; 120(3):663-9. PubMed ID: 19649706
[TBL] [Abstract][Full Text] [Related]
18. A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population.
Sun J; Zhu M; Shen W; Wang C; Dai J; Xu L; Jin G; Hu Z; Ma H; Shen H
Pharmacogenomics J; 2017 Jun; 17(3):280-285. PubMed ID: 26951883
[TBL] [Abstract][Full Text] [Related]
19. Relationship between circulating lung-specific X protein messenger ribonucleic acid expression and micrometastasis and prognosis in patients with early-stage nonsmall cell lung cancer.
Cui Y; Wang W; Yao S; Qiu Z; Cong L
J Cancer Res Ther; 2020; 16(7):1641-1647. PubMed ID: 33565511
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in one-carbon metabolism-related genes contribute to NSCLC prognosis in a Chinese population.
Jin G; Huang J; Hu Z; Dai J; Tang R; Chen Y; Xu L; Huang X; Shu Y; Shen H
Cancer; 2010 Dec; 116(24):5700-9. PubMed ID: 20737570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
